GLOBOCAN 2022

CHINA
Number of new cases Number of deaths Number of prevalent cases
(5-year)

4 824 703 2 574 176 10 968 974

Statistics at a glance, 2022
Males Females Both sexes
Population 721 007 012 690 742 994 1 411 750 006

Incidence* China

Number of new cancer cases 2 533 906 2 290 797 4 824 703

Age-standardized incidence rate 209.6 197.0 201.6

Risk of developing cancer before the age 21.8 19.3 20.5

of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Lung Lung Lung

cases)**
Colorectum Breast Colorectum
Liver Thyroid Thyroid

Mortality*

Number of cancer deaths 1 629 288 944 888 2 574 176

Age-standardized mortality rate 127.5 67.8 96.5

Risk of dying from cancer before the age 13.5 7.1 10.3
of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Lung Lung Lung

deaths)**
Liver Colorectum Liver
Stomach Liver Stomach

Prevalence* Kilometers

0 250 500 1000

5-year prevalent cases 4 991 699 5 977 275 10 968 974

Top 5 most frequent cancers**

Males Females Both sexes

Lung
Lung
Lung

Others
Others

Others

Breast
Colorectum

Colorectum

Oesophagus Thyroid
Cervix uteri
Thyroid
Liver
Stomach Colorectum Stomach Liver

Total: 2 533 906 Total: 2 290 797 Total: 4 824 703

Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent

1st Lung 658 722 26.0% 1st Lung 401 862 17.5% 1st Lung 1 060 584 22.0%

2nd Colorectum 307 688 12.1% 2nd Breast 357 161 15.6% 2nd Colorectum 517 106 10.7%

3rd Liver 267 898 10.6% 3rd Thyroid 341 211 14.9% 3rd Thyroid 466 118 9.7%

4th Stomach 246 550 9.7% 4th Colorectum 209 418 9.1% 4th Liver 367 657 7.6%

5th Oesophagus 167 472 6.6% 5th Cervix uteri 150 659 6.6% 5th Stomach 358 672 7.4%

- Others 885 576 34.9% - Others 830 486 36.3% - Others 2 054 566 42.6%

Number of new cases in 2022, males, all ages Number of new cases in 2022, females, all ages Number of new cases in 2022, both sexes, all ages

The Global Cancer Observatory | All rights reserved | Globocan 2022 (version 1.1) - 08.02.2024 Page 1
 Incidence, Mortality and Prevalence by cancer site

New cases Deaths 5-year prevalence

Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)

Lung 1 060 584 1 22.0 4.9 733 291 1 28.5 3.1 1 412 775 100.1

Colorectum 517 106 2 10.7 2.4 240 010 4 9.3 0.89 1 477 561 104.7

Thyroid 466 118 3 9.7 2.3 11 564 22 0.45 0.05 1 631 663 115.6

Liver 367 657 4 7.6 1.7 316 544 2 12.3 1.4 483 407 34.2

Stomach 358 672 5 7.4 1.7 260 372 3 10.1 1.1 523 812 37.1

Breast 357 161 6 7.4 3.5 74 986 7 2.9 0.67 1 160 496 168.0

Oesophagus 224 012 7 4.6 1.0 187 467 5 7.3 0.79 296 960 21.0

Cervix uteri 150 659 8 3.1 1.5 55 694 9 2.2 0.51 476 293 69.0

Prostate 134 156 9 2.8 1.1 47 522 11 1.8 0.23 304 527 42.2

Pancreas 118 672 10 2.5 0.52 106 295 6 4.1 0.45 111 752 7.9

Bladder 92 883 11 1.9 0.39 41 367 12 1.6 0.12 276 102 19.6

Brain CNS 87 498 12 1.8 0.43 56 648 8 2.2 0.27 319 919 22.7

Leukaemia 81 946 13 1.7 0.41 50 074 10 1.9 0.24 244 630 17.3

NHL 80 829 14 1.7 0.40 39 700 13 1.5 0.17 248 984 17.6

Corpus uteri 77 722 15 1.6 0.77 13 511 21 0.53 0.12 282 746 40.9

Kidney 73 656 16 1.5 0.37 23 991 17 0.93 0.10 218 877 15.5

Ovary 61 060 17 1.3 0.61 32 646 14 1.3 0.31 180 870 26.2

Nasopharynx 51 010 18 1.1 0.26 28 408 15 1.1 0.14 157 389 11.2

Lip, oral cavity 37 208 19 0.77 0.18 20 831 18 0.81 0.09 106 677 7.6

Gallbladder 31 132 20 0.65 0.13 24 543 16 0.95 0.10 41 039 2.9

Multiple myeloma 30 300 21 0.63 0.15 18 662 19 0.73 0.09 85 184 6.0

Larynx 29 461 22 0.61 0.15 16 852 20 0.66 0.07 90 473 6.4

Salivary glands 10 434 23 0.22 0.05 3 647 26 0.14 0.02 33 159 2.4

Hypopharynx 9 549 24 0.20 0.05 5 775 23 0.22 0.03 18 459 1.3

Melanoma 8 789 25 0.18 0.04 5 385 24 0.21 0.02 29 059 2.1

Oropharynx 7 941 26 0.17 0.04 4 924 25 0.19 0.02 21 837 1.6

Penis 5 973 27 0.12 0.06 2 275 27 0.09 0.02 18 109 2.5

Hodgkin lymphoma 4 363 28 0.09 0.02 1 931 29 0.08 0.01 14 285 1.0

Vulva 4 117 29 0.09 0.04 1 956 28 0.08 0.01 12 286 1.8

Testis 3 486 30 0.07 0.03 782 32 0.03 0.01 12 719 1.8

Vagina 2 685 31 0.06 0.03 1 057 31 0.04 0.01 7 169 1.0

Mesothelioma 2 381 32 0.05 0.01 1 681 30 0.07 0.01 3 395 0.24

All cancers 4 824 703 - - 20.5 2 574 176 - - 10.3 10 968 974 -

All cancers excl. NMSC 4 775 419 - - 20.3 2 560 612 - - 10.3 10 811 657 -

Data source and methods

Incidence Incidence Mortality Males Females

Country-specific data source: 919 sub-national registries Lung 40.8 26.7 Lung 52.0 30.3

Method: Weighted/simple average of the most recent sub- Breast 33.0 6.1 Breast 33.0

national rates applied to 2022 population

Thyroid 24.6 0.5 Colorectum 24.7 15.7

Colorectum 20.1 8.6 Liver 22.7 7.4

Click here to see detailed data source and methods

Liver 15.0 12.6 Stomach 19.5 8.3

Mortality Cervix uteri 13.8 4.5 Cervix uteri 13.8

Stomach 13.7 9.4 Thyroid 13.3 36.5

Country-specific data source: No data

Prostate 9.7 3.3 Oesophagus 13.1 3.8
Method: Estimated from national mortality estimates by
Oesophagus 8.3 6.7 Prostate 9.7
modelling, using mortality:incidence ratios derived from survival

estimation Corpus uteri 6.8 1.1 Corpus uteri 6.8

Ovary 5.7 2.6 Ovary 5.7

Click here to see detailed data source and methods

Leukaemia 4.5 2.4 Bladder 5.7 1.4

Prevalence
Pancreas 4.4 3.9 Pancreas 5.3 3.6

Brain CNS 4.2 2.5 Leukaemia 5.1 3.9

Computed using sex-; site- and age-specific incidence to 1-;3- NHL 3.5 1.6 Brain CNS 4.1 4.2

and 5-year prevalence ratios from Nordic countries for the period
60 50 40 30 20 10 0 10 20 30 40 50 60 80 60 40 20 0 20 40 60 80
(2011-2020), and scaled using Human Development Index (HDI)

ratios.

ASR (World) incidence and mortality rates, top 15 cancers** ASR (World) incidence rates per sex, top 15 cancers**

Page 2

* includes non-melanoma skin cancer (NMSC)

** NMSC included in other cancers

Age standardization using world population (see link)

References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.

2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).

Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.

© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today